Gilpin Wealth Management Expands Holdings with Key Investments in Dividend Growth, Mid-Cap ETFs

Gilpin’s Q4 purchase of iShares Core Dividend Growth ETF (DGRO) was for 21,915 shares valued at about $1,521,000, and the firm said DGRO is its 22nd-largest portfolio position.
Gilpin’s Q4 entry into iShares Core S&P Mid-Cap ETF (IJH) totaled 17,478 shares valued at approximately $1,154,000.
Gilpin’s Q4 investment in SPDR Bloomberg 1–3 Month T-Bill ETF (BIL) involved 23,876 shares valued at roughly $2,182,000, and BIL is identified as its 14th-largest holding.
For Gilpin’s Emerson Electric (EMR) stake, the article notes that hedge funds and other institutional investors own 74.30% of the stock; it also cites a Wolfe Research move that lowered EMR’s target price from $176 to $169 while maintaining an “outperform” rating.
Gilpin Wealth Management LLC added 21,915 shares of the iShares Core Dividend Growth ETF (DGRO) in Q4 2025, valued at roughly $1,521,000, according to WatchlistNews. The purchase makes DGRO the firm's 22nd-largest holding, representing about 1.2% of its portfolio.
The Denver-based wealth manager also opened new positions in two other funds during the quarter. It bought 17,478 shares of the iShares Core S&P Mid-Cap ETF (IJH) for about $1,154,000 and 23,876 shares of the SPDR Bloomberg 1–3 Month T-Bill ETF (BIL) for roughly $2,182,000. BIL is now Gilpin's 14th-largest position at about 1.7% of the portfolio.
DGRO tracks companies with a history of raising their dividends. It gives Gilpin exposure to steady, cash-generating businesses without the risk of picking individual stocks. The ETF is managed by BlackRock under its iShares brand.
The IJH purchase adds mid-cap exposure — companies that are larger than small-caps but not yet in the top tier. At $1,154,000, it is a smaller bet than DGRO, but it signals that Gilpin is broadening beyond large-cap names. Both moves point to a strategy that leans on low-cost index funds as a portfolio core, according to WatchlistNews.
The BIL fund holds U.S. Treasury bills that mature in one to three months. It acts like a cash equivalent — safe, liquid, and earning short-term interest. At $2,182,000, it is actually the largest single new position Gilpin opened in Q4.
Putting BIL at the 14th spot in the portfolio suggests Gilpin is keeping a meaningful slice of assets in near-cash form. This is a common move when wealth managers are unsure about near-term market direction. Higher-for-longer interest rates have made short-term Treasuries more attractive than in prior years, according to WatchlistNews.
Beyond ETFs, Gilpin also bought shares of Stryker (SYK) and Emerson Electric (EMR). Stryker is a medical device maker with a market cap of about $139.2 billion. Emerson is an industrial conglomerate. Both are large, well-known names with broad institutional backing.
Hedge funds and other institutions own 74.30% of Emerson Electric's stock, according to WatchlistNews. In April 2026, Wolfe Research lowered its price target on EMR from $176 to $169 but kept an "outperform" rating — meaning analysts still see room for the stock to rise despite the cut.
Gilpin filed these holdings as part of a Form 13F — a report required by the SEC for any manager with over $100 million in qualifying assets. The deadline for Q4 filings was February 14, 2026. The disclosures let investors track where professional money managers are putting capital.
Based on DGRO's 1.2% share and BIL's 1.7% share of the total portfolio, Gilpin's assets under management are estimated at roughly $126 million to $128 million, according to data derived from SEC filings and reported by WatchlistNews. The moves suggest a firm that is balancing growth exposure with a defensive cash sleeve.
Publishers
22
Articles
2
Reach
24